PyInvesting

Market research

EXE.TO Extendicare Inc

TO CAD Healthcare

Latest close

26.57 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
3B
P/E ratio
20.91
Analyst target
38.9444
Dividend yield
1.9%
Beta
1.07

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Extendicare Inc is currently in a long term uptrend where the price is trading 21.3% above its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.

Extendicare Inc's total revenue rose by 5.8% to $308M since the same quarter in the previous year.

Its net income has increased by 73.2% to $17M since the same quarter in the previous year.

Finally, its free cash flow grew by 678.6% to $27M since the same quarter in the previous year.

Based on the above factors, Extendicare Inc gets an overall score of 5/5.